Project Acronym:

Project Reference:

Duration: 52 months

Contract Type:
Small or medium-scale
focused research project

Project Funding:
6 million euros

Research area:
HEALTH.2012.2.4.5-2 Biomarkers and diagnostics for chronic inflammatory diseases of the joint and/or digestive system

This project has received funding from the European Union's Seventh Framework Program for research, technological development and demonstration under grant agreement #305676


More than five million people live with an inflammatory bowel disease worldwide

Inflammatory bowel diseases are characterized by severe chronic intestinal inflammation with huge impact on quality of life. Current treatment is expensive and lacks in therapeutic precision. This reduces efficacy and safety and the disease progress throughout life as well as causes un-necessary side effects from patients receiving treatment they do not respond to.  Delaying the onset of the disease as well as finding novel potential targets for intervention strategies would dramatically increase the likelihood of healthy, active and independent lives until old age.

How inflammatory bowel disease is manifested depend on the area of the intestinal tract involved. Many of the symptoms, however, are not specific for this disease. The World Gastroenterology Organization indicates the following symptoms may be associated with inflammatory damage in the digestive tract

  • Diarrhea
  • Bowel movement abnormalities:
  • Abdominal cramping and pain:
  • Nausea and vomiting:

If you suspect yourself of having IBD please consult your local physician.

Patients included in this study are recruited via the normal admission to hospitals within the regions where project partners are active. No recruitment will be made outside those regions.

More information about IBD can be found on: (A project funded under FP7) (European Federation of Crohn's & Ulcerative Colitis Association)